Related Experiment Videos

Anaesthesia for electroconvulsive therapy: use of propofol revisited

B Fredman1, M M Husain, P F White

  • 1Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Centre, Dallas 75235-9068.

Insights

Electroconvulsive therapy (ECT) with propofol showed dose-dependent seizure duration. Minimally hypnotic propofol doses maintained seizure activity comparable to methohexitone, suggesting safety for ECT.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is a vital treatment for severe depression.
  • Anesthetic agents like propofol and methohexitone are used during ECT.
  • Seizure duration is a critical parameter for ECT efficacy and safety.

Observation:

  • Three patients with clinical depression undergoing ECT were studied.
  • Both propofol and methohexitone were administered as anesthetic agents.
  • Dose-dependent effects on motor and electroencephalogram (EEG) seizure duration were observed.

Findings:

  • Lower doses of propofol (0.75-1.0 mg kg-1) resulted in seizure durations comparable to standard methohexitone doses.
  • Propofol exhibited a dose-dependent reduction in seizure duration.
  • Propofol doses below 1.5 mg kg-1 were associated with clinically acceptable EEG seizure durations (> 30 seconds).

Implications:

  • Propofol, at specific doses, can be a suitable anesthetic for ECT.
  • Careful dose titration of propofol may optimize seizure duration during ECT.
  • These findings support the use of lower propofol doses in ECT to balance anesthesia and therapeutic seizure activity.

Related Concept Videos